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A 28-year-old man with 3 months of chest heaviness presented with one week of fever. This oil refinery worker at Kaohsiung, Taiwan, had received 3 years of renal replacement therapy for vesicoureteral reflux. Chest radiography showed bilateral costophrenic angle blunting (Fig. 1A) . Echocardiography showed a thickened pericardium with an effusion, severe right ventricular hypokinesis, and preserved left ventricle systolic function. Straw-colored fluid with 950 leukocytes/mL (polymorphonuclear leukocytes [PMNs] 22%, lymphocytes 45%, and monocytes 33%) was drained via thoracotomy. Acidfast bacillus staining of sputum and pericardial fluid was negative. Blood culture yielded no growth. Polymerase chain reaction testing was negative for Mycobacterium tuberculosis. Pericardial biopsy revealed acute and chronic inflammatory cell infiltration. Anti-tuberculous chemotherapy plus adjuvant corticosteroid therapy were prescribed with the impression of tuberculous pericarditis. However, fever and dyspnea on exertion developed after the steroid dose was reduced. Echocardiography revealed limited pericardial motion with a small effusion. Pericardiectomy was performed for effusive-constrictive pericarditis. Pericardial fluid revealed 612 leukocytes/mL (PMNs 2%, lymphocytes 59%, and monocytes 39%). Aerobic and anaerobic cultures were still negative. Blood cultures became positive for a Gram-negative bacillus after 4 days of incubation (BACTECä FX; BD Diagnostics, Sparks, MD, USA). Subcultures on blood agar yielded circular, convex, smooth, golden-yellow, non-hemolytic colonies but poor growth on EMB agar after 24 h of incubation at 35 C with 5% CO 2 . These colonies increased in size to about 1.5e2.5 mm in diameter after 72 h of incubation. P. kaohsiungensis was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (Bruker Daltonik, Bremen, Germany) using Bruker Biotyper 3.1 System. The identification score value was 2.36 and its identification was subsequently confirmed by 16S rRNA (99.0% identical; accession number NR043070). Susceptibility (Fig. 1C) was assessed using the Phoenix automated microbiology system (BD Diagnostics). Categorical interpretations for minimal inhibitory concentration tests used the Clinical and Laboratory Standards Institute (CLSI) criteria for other non-Enterobacteriaceae. 2 Fever subsided on the third day of using ceftazidime. Echocardiography after 2 weeks of ceftazidime revealed slight pericardial sliding, little pericardial effusion, and inferior vena cava collapse with inspiration. The patient was discharged with oral ciprofloxacin for 2 weeks. He remained well, and the pleura-pericardial effusion resolved after 6 months (Fig. 1B) , with no constrictive findings.
cultured from pericardial fluid because agar plates are often discarded after 3 days of incubation. The presence of pericardial effusion coincided with bacteremia in this oil refinery worker that resolved on antibiotics, making P.
kaohsiungensis the likely cause of pericarditis. The evidence suggests that this organism is a potential human pathogen in an immunocompromised host, rather than simply a biosurfactant-producing bacterium in the environment. 
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